Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
14
Total Shares
324,702
Total Value
$3,464,320.01
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 5, 2026 | Exercise/Conversion | 1,000 | $12.65 | $12,650.00 | 4,622 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 5, 2026 | Exercise/Conversion | 679 | $8.04 | $5,459.16 | 5,301 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 5, 2026 | Sale | 1,679 | $16.00 | $26,864.00 | 3,622 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Exercise/Conversion | 77,905 | $12.65 | $985,498.25 | 81,527 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Exercise/Conversion | 28,650 | $8.04 | $230,346.00 | 110,177 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Sale | 27,538 | $18.03 | $496,405.50 | 82,639 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Sale | 5,000 | $19.65 | $98,251.00 | 77,639 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Sale | 44,944 | $21.20 | $952,668.98 | 32,695 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Sale | 19,015 | $22.41 | $426,050.09 | 13,680 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Sale | 10,058 | $22.88 | $230,127.04 | 3,622 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 5, 2026 | Exercise/Conversion | 1,000 | $0.00 | $0.00 | 209,530 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 5, 2026 | Exercise/Conversion | 679 | $0.00 | $0.00 | 147,650 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 6, 2026 | Exercise/Conversion | 77,905 | $0.00 | $0.00 | 131,625 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 6, 2026 | Exercise/Conversion | 28,650 | $0.00 | $0.00 | 119,000 | Direct | โ | View Details |